Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$316.89M
↑ 206% above average
Average (9y)
$-298.85M
Historical baseline
Range
High:$316.89M
Low:$-658.71M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $316.89M | +169.8% |
| 2023 | $-453.69M | +23.7% |
| 2022 | $-594.85M | -87.4% |
| 2021 | $-317.41M | +30.0% |
| 2020 | $-453.38M | +31.2% |
| 2019 | $-658.71M | -108.0% |
| 2018 | $-316.66M | -811.1% |
| 2017 | $-34.76M | +86.7% |
| 2016 | $-261.12M | -21.6% |
| 2015 | $-214.78M | - |